Article debunks claims that gene editing will revolutionise crop breeding in Africa
By Claire Robinson,
GMWatch
| 01. 24. 2023
Gene editing has captured the imagination of academics and professionals working on agricultural development in Africa. They claim the technology has the potential to revolutionise crop breeding, based on assertions of precision, cheapness and speed.
However, these claims are strongly challenged in a new peer-reviewed article by an international group of development experts led by Joeva Sean Rock, Professor of Development Studies at the University of Cambridge, UK. The authors review the evidence and experience of older-style GM crops in Africa, as well as the research findings to date on gene editing. They conclude that unless hard lessons are learned from experience with first-generation GM crops, gene editing projects "are in danger of repeating mistakes of the past".
The article is open access and written in an easy-to-understand style, and we recommend reading it in full.
We've heard it before
The authors find that the narratives around gene editing closely echo the earlier ones underpinning the introduction of older-style GM crops into Africa: "But the reality of GM crops in Africa has not lived up to the hype". Problems include...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...